Shinouchi, R.; Turgutalp, B.; Ople, R.S.; Eans, S.O.; Williams, A.K.; Hammond, H.R.; Varadi, A.; Dardashti, R.N.; Majumdar, S.; McLaughlin, J.P.
Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic Pain. Pharmaceuticals 2026, 19, 117.
https://doi.org/10.3390/ph19010117
AMA Style
Shinouchi R, Turgutalp B, Ople RS, Eans SO, Williams AK, Hammond HR, Varadi A, Dardashti RN, Majumdar S, McLaughlin JP.
Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic Pain. Pharmaceuticals. 2026; 19(1):117.
https://doi.org/10.3390/ph19010117
Chicago/Turabian Style
Shinouchi, Ryosuke, Bengisu Turgutalp, Rohini S. Ople, Shainnel O. Eans, Ashai K. Williams, Haylee R. Hammond, Andras Varadi, Rebecca Notis Dardashti, Susruta Majumdar, and Jay P. McLaughlin.
2026. "Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic Pain" Pharmaceuticals 19, no. 1: 117.
https://doi.org/10.3390/ph19010117
APA Style
Shinouchi, R., Turgutalp, B., Ople, R. S., Eans, S. O., Williams, A. K., Hammond, H. R., Varadi, A., Dardashti, R. N., Majumdar, S., & McLaughlin, J. P.
(2026). Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic Pain. Pharmaceuticals, 19(1), 117.
https://doi.org/10.3390/ph19010117